FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). That means compounded versions of these drugs…

Read More

What’s Trump Done on Prescription Drug Prices So Far – and What Might Be Next?

Early moves by the president raise questions about what direction his second-term policy on drug costs will take. Amid a flurry of executive actions on his first day back in office, President Donald Trump gave the first official indications of his administration’s approach to health care by scrapping existing orders aimed at expanding health coverage under the Affordable Care Act and strengthening…

Read More

What to Know About Record Kansas Tuberculosis Outbreak

Kansas is currently experiencing the largest-ever reported outbreak of tuberculosis in the U.S. Health officials are contending with an ongoing outbreak of tuberculosis in the Kansas City metro area that reportedly has become the largest in U.S. history. “Currently, Kansas has the largest outbreak that they’ve ever had in history,” Ashley Goss, a deputy secretary at the…

Read More

Huge Health Challenges Face Gaza Residents Returning to Their Homes

As Gaza residents return to what is left of their homes, they’re facing new risks on top of monumental health challenges Hospitals and clinics destroyed. Millions of tons of debris contaminated with toxic substances, unexploded ordnance and human remains. Tens of thousands of people with injuries that will require a lifetime of care. As Gaza’s residents…

Read More